1. Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MdP, Acosta-Torres LS, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 2018;16:1-33. [DOI:10.1186/s12951-018-0392-8]

2. Sharma P, Mehta M, Dhanjal DS, Kaur S, Gupta G, Singh H, et al. Emerging trends in the novel drug delivery approaches for the treatment of lung cancer. Chem Biol Interact 2019;309:108720. [DOI:10.1016/j.cbi.2019.06.033]

3. Bhutani U, Basu T, Majumdar S. Oral drug delivery: conventional to long acting new-age designs. Eur J Pharm Biopharm 2021;162:23-42. [DOI:10.1016/j.ejpb.2021.02.008]

4. Kulinsky L, Madou M. BioMEMs for drug delivery applications. In: Bhansali S, Vasudev A, eds. MEMS for Biomedical Applications. Sawston, United Kingdom: Woodhead Publishing; 2012. p.218-68. [DOI:10.1533/9780857096272.3.218]

5. Motakef-Kazemi N, Shojaosadati SA, Morsali A. In situ synthesis of a drug-loaded MOF at room temperature. Microporous and Mesoporous Materials 2014;186:73-9. [DOI:10.1016/j.micromeso.2013.11.036]

6. Kotcherlakota R, Das S, Patra CR. Therapeutic applications of green-synthesized silver nanoparticles. In: Kumar Shukla A, Iravani S, eds. Micro and Nano Technologies, Green Synthesis, Characterization and Applications of Nanoparticles. Amsterdam, Netherlands: Elsevier; 2019. p.389-428. [DOI:10.1016/B978-0-08-102579-6.00017-4]

7. Kitagawa S. Metal-organic frameworks (MOFs). Chem Soc Rev 2014;43:5415-8. [DOI:10.1039/C4CS90059F]

8. Gangu KK, Maddila S, Mukkamala SB, Jonnalagadda SB. A review on contemporary metal-organic framework materials. Inorganica Chimica Acta 2016;446:61-74. [DOI:10.1016/j.ica.2016.02.062]

9. Lawson HD, Walton SP, Chan C. Metal-organic frameworks for drug delivery: a design perspective. ACS Appl Mater Interfaces 2021;13:7004-20. [DOI:10.1021/acsami.1c01089]

10. Lee J, Farha OK, Roberts J, Scheidt KA, Nguyen ST, Hupp JT. Metal-organic framework materials as catalysts. Chem Soc Rev 2009;38:1450-9. [DOI:10.1039/b807080f]

11. Baek J, Rungtaweevoranit B, Pei X, Park M, Fakra SC, Liu Y-S, et al. Bioinspired metal-organic framework catalysts for selective methane oxidation to methanol. J Am Chem Soc 2018;140:18208-16. [DOI:10.1021/jacs.8b11525]

12. Ghanbari T, Abnisa F, Daud WMAW. A review on production of metal organic frameworks (MOF) for CO2 adsorption. Sci Total Environ 2020;707:135090. [DOI:10.1016/j.scitotenv.2019.135090]

13. Ge X, Wong R, Anisa A, Ma S. Recent development of metal-organic framework nanocomposites for biomedical applications. Biomaterials 2022;281:121322. [DOI:10.1016/j.biomaterials.2021.121322]

14. Motakef-Kazemi N, Shojaosadati SA, Morsali A. Evaluation of the effect of nanoporous nanorods Zn 2 (bdc) 2 (dabco) dimension on ibuprofen loading and release. Journal of the iranian chemical society. 2016;13:1205-12. doi.org/10.1007/s13738-016-0835-9 [DOI:10.1007/s13738-016-0835-9]

15. Rahvar Y, Motakef-Kazemi N, Hosseini Doust R. Synthesis of Zn2 (BDC) 2 (DABCO) MOF by solution and solvothermal methods and evaluation of its anti-bacterial. Nanomed Res J 2021;6:360-8.

16. Rahmani F, Jafariazar Z, Mousavi Z, Kazemi NM. Synthesis of Zn2 (BDC) 2 (DABCO) Metal-Organic Framework and Its Polyethylene Glycol Composite for Acetaminophen Delivery. Iranian Journal of Science. 2024;48:1-11. [DOI:10.1007/s40995-023-01544-1]

17. Organisation for Economic Co-operation and Development (OCED). Test no. 407: repeated dose 28-day oral toxicity study in rodents. Paris: OECD Publishing; 2008.

18. Lan S, Zhang J, Li X, Pan L, Li J, Wu X, et al. Low toxicity of metal-organic framework MOF-74 (Co) nano-particles in vitro and in vivo. Nanomaterials 2022;12:3398. [DOI:10.3390/nano12193398]

19. Chen G, Leng X, Luo J, You L, Qu C, Dong X, et al. In vitro toxicity study of a porous iron (III) metal-organic framework. Molecules 2019;24:1211. [DOI:10.3390/molecules24071211]

20. Ren F, Yang B, Cai J, Jiang Y, Xu J, Wang S. Toxic effect of zinc nanoscale metal-organic frameworks on rat pheochromocytoma (PC12) cells in vitro. J Hazard Mater 2014;271:283-91. [DOI:10.1016/j.jhazmat.2014.02.026]

21. Baati T, Njim L, Neffati F, Kerkeni A, Bouttemi M, Gref R, et al. In depth analysis of the in vivo toxicity of nanoparticles of porous iron (III) metal-organic frameworks. Chem Sci 2013;4:1597-607. [DOI:10.1039/c3sc22116d]

22. Liu C-H, Chiu H-C, Sung H-L, Yeh J-Y, Wu KC-W, Liu S-H. Acute oral toxicity and repeated dose 28-day oral toxicity studies of MIL-101 nanoparticles. Regul Toxicol Pharmacol 2019;107:104426. [DOI:10.1016/j.yrtph.2019.104426]